Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
AVITA Medical at-the-market offering
The stock is listed on the Nasdaq Global Market
InflaRx follow-on offering
The shares are listed on the Nasdaq Global Market
Medtronic Global Holdings $2 billion notes offering
The investment-grade offering comprises two tranches of notes
Intercept Pharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Kenvue $7.75 billion senior notes offering
The investment-grade offering comprises eight tranches of notes
Atairos acquisition of LifeLabs Learning
We are advising Atairos on the transaction
Cigna $1.5 billion senior notes offering
The senior notes are due 2026 and 2033
Revolution Medicines $345 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Ardelyx $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
European Biotech Acquisition $220 million combination with Oculis
We advised European Biotech Acquisition on its de-SPAC transaction